AI companies used Super Bowl commercials to make a play for mainstream acceptance, much like cryptocurrency firms attempted during the big game in 2022.

Violations of the New Mexico Food Code are often corrected on-site during an inspection. Some require a reinspection within three business days.

Eli Lilly is tackling a high-growth market: weight loss. The company’s weight loss portfolio brought in $10 billion in the recent quarter. Eli Lilly (NYSE: LLY) has behaved more like a tech stock in ...

Eli Lilly leads the weight loss market ahead of Novo Nordisk. Eli Lilly also has a more diversified lineup of products than its peer. Even considering its seemingly more reasonable valuation, Novo ...

How Evangeline Lilly is doing now. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. In May 2025, Evangeline Lilly posted on her Substack that she ...

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models by making ...

Texas put its signature on one of its biggest economic development wins yet under a new incentive regime, officially clearing the way for Eli Lilly’s $6.5 billion manufacturing plant in northeast ...

As evidence of tirzepatide’s efficacy mounts across a range of cardiometabolic conditions, Eli Lilly has shown that taking the incretin medicine alongside another of its drugs, Taltz, could lead to ...

Eli Lilly and Company remains a Buy, supported by robust incretin-driven growth and strategic expansion in obesity treatments. LLY pivots from scarcity to access economics, prioritizing volume over ...

Eli Lilly (LLY 2.12%) is close to doing something no other pharmaceutical company has ever done: reaching $1 trillion in market value. The company briefly touched that level in November but has since ...

Eli Lilly has returned to Nimbus Therapeutics for another metabolic collaboration, this time focused on the red-hot R&D space of oral obesity therapies. The latest partnership will see Lilly pass ...